Extensive-stage small-cell lung cancer-025EFmoving beyond response rate?

被引：2

作者：

Ferraldeschi, R. ^{[1
]}

Lorigan, P. ^{[1
]}

机构：

[1] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷 / 05期

关键词：

PHASE-III; 1ST-LINE CHEMOTHERAPY; COLORECTAL-CANCER; TRIALS; METAANALYSIS; SURVIVAL; PREDICTORS; MANAGEMENT; CISPLATIN;

D O I：

10.1093/annonc/mdp247

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：801 / 802

页数：2

共 18 条

[1] Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials [J].

Bozcuk, H ;

Artac, M ;

Ozdogan, M ;

Savas, B .

CANCER, 2005, 104 (12) :2650-2657

[2] Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients [J].

Bruzzi, P ;

Del Mastro, L ;

Sormani, MP ;

Bastholt, L ;

Danova, M ;

Focan, C ;

Fountzilas, G ;

Paul, J ;

Rosso, R ;

Venturini, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5117-5125

[3] Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis [J].

Buyse, M ;

Thirion, P ;

Carlson, RW ;

Burzykowski, T ;

Molenberghs, G ;

Piedbois, P .

LANCET, 2000, 356 (9227) :373-378

[4] Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress [J].

Chute, JP ;

Chen, T ;

Feigal, E ;

Simon, R ;

Johnson, BE .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1794-1801

[5]

El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913

[6] Modern management of small-cell lung cancer [J].

Ferraldeschi, Roberta ;

Baka, Sofia ;

Jyoti, Babita ;

Faivre-Finn, Corinne ;

Thatcher, Nick ;

Lorigan, Paul .

DRUGS, 2007, 67 (15) :2135-2152

[7] Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval [J].

Goffin, J ;

Baral, S ;

Tu, DS ;

Nomikos, D ;

Seymour, L .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5928-5934

[8]

HEIGENER D, 2008, J CLIN ONCOL, V26

[9] Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer [J].

Hotta, K. ;

Kiura, K. ;

Fujiwara, Y. ;

Takigawa, N. ;

Oze, I. ;

Ochi, N. ;

Tabata, M. ;

Tanimoto, M. .

ANNALS OF ONCOLOGY, 2009, 20 (05) :829-834

[10] Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study [J].

Jeremic, B ;

Shibamoto, Y ;

Nikolic, N ;

Milicic, B ;

Milisavljevic, S ;

Dagovic, A ;

Aleksandrovic, J ;

Radosavljevic-Asic, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2092-2099

← 1 2 →